BennMWattsGFTybjaerg-HansenANordestgaardBG (2012) Familial hypercholesterolaemia in the Danish general population: Prevalence, coronary artery disease, and cholesterol-lowering medication. The Journal of Clinical Endocrinology and Metabolism97(11): 3956–3964. doi: 10.1210/jc.2012-1563.
2.
CuchelMBrucketEGinsbergHNRaalFJSantosRDHegeleRAChapmanMJ (2014) Homozygous familial hypercholesterolaemia: New insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. European Heart Journal35(32): 2146–2157. doi: 10.1093/eurheartj/ehu274.
3.
NeilACooperJBetteridgeJCappsNMcDowellIDurringtonPHumphriesS. E (2008) Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: A prospective registry study. European Heart Journal29(21): 2625–2633. doi: 10.1093/eurheartj/ehn422.
4.
NeilHASeagroattVBetteridgeDJCooperMPDurringtonPNMillerJPHumphriesSE (2004) Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia. Heart90(12): 1431–1437. doi: 10.1136/hrt.2003.022764.
NICE (2016a) Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia. Retrieved from www.nice.org.uk/guidance/TA393.
7.
NICE (2016b) Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia. Retrieved from www.nice.org.uk/guidance/TA394.
8.
PerkJDe BackerGGohikeHGrahamIReinerZVerschurenMZannadFEuropean guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European Heart Journal33(13): 1635–1701. doi: 10.1093/eurheartj/ehs092.
9.
RamaswamiUCooperJHumphriesSE (2016) The UK paediatric familial hypercholesterolaemia register: Preliminary data. Archives of Disease in Children102(3): 255–260.
10.
SeguroFBongardVBerardETaraszkiewiczDRuidavetsJBFerrieresJ (2015) Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population. Archives of Cardiovascular Diseases108(10): 511–518. doi: 10.1016/j.acvd.2015.04.003.
11.
Sabatine, MS, Guigliano, RP, Keech, AC, Honarpour, N, Wiviott, SD, Murphy, SA, … Pedersen, TR (2017) Evolocumab and clinical outcomes in patients with cardiovascular disease. New England Journal of Medicine. Epub ahead of print. DOI: 10.1056/NEJMoa1615664.
